top of page
Search

United Therapeutics Announces Commercial Launch Of The Remunity Pump For Remodulin

United Therapeutics Announces Commercial Launch Of The Remunity Pump For Remodulin


"The team at United Therapeutics have been relentless in their quest to improve the lives of patients with PAH. The Remunity Pump is the next step in their critical mission. Everyone at DEKA is extremely proud to be launching our innovative delivery technology with United Therapeutics," said Dean Kamen, Founder and President of DEKA. "While the COVID-19 pandemic has been devastating to all of us, the DEKA team has never forgotten that the PAH community is particularly vulnerable. This stark reality, along with the unwavering commitment by the UT team, has continued to energize us to reach this significant goal. We are confident that the Remunity Pump, particularly with cassettes prefilled with Remodulin, has the potential to improve the lives of the patients who depend on United Therapeutics."



021021 United Therapeutics Announces Com
.
Download • 61KB

The Remunity Pump was initially cleared by the FDA in May 2019 with instructions for patient filling. An additional 510(k) clearance in February 2020 enables cassettes to be prefilled with Remodulin by contracted specialty pharmacies in order to improve convenience for patients..."


bottom of page